FMC Secures Approval for Isoflex® Active in the European Union, Addressing a Critical Gap in the European Herbicide Market
FMC (NYSE: FMC) announced EU regulatory approval for Isoflex® active (bixlozone) on April 6, 2026.
Rhea-AI Summary
FMC (NYSE: FMC) announced EU regulatory approval for Isoflex® active (bixlozone) on April 6, 2026. The approval enables filing of formulated products for cereals, corn, oilseed rape and potato covering more than 55 million planted hectares in the EU, with product launches anticipated beginning in 2027.
Isoflex® active is HRAC Group 13 and offers a new mode of action to manage resistant grass and broadleaf weeds; global registrations exist in multiple countries and R&D continues for additional crops.
Positive
- EU approval for Isoflex active expands market access
- Potential coverage of 55 million+ planted hectares in cereals, corn, oilseed rape and potato
- Launch timeline anticipated beginning in 2027
- New mode of action (HRAC Group 13) to manage resistant weeds
Negative
- Commercial launches remain subject to pending regulatory decisions on product dossiers
- Market benefit depends on successful national registrations and grower adoption across EU jurisdictions
Details
News Market Reaction – FMC
On Apr 7, the first trading day after this news, FMC closed 2.50% above the previous close.
Data tracked by StockTitan Argus for the Apr 7 session.
Key Figures
- Planted hectares potential
- more than 55 million hectares
- Cereals, corn, oilseed rape and potato in the EU
- Last herbicide approval year
- 2019
- Last herbicide approval in EU before Isoflex® active
- Herbicide actives lost
- more than 20 active ingredients
- Herbicide active ingredients EU growers lost access to since 2019
- Planned launch timing
- 2027
- Anticipated start of EU product launches powered by Isoflex® active
Historical Context
-
Announced timing for Q1 2026 earnings release and webcast.
-
CEO and CFO scheduled to speak at J.P. Morgan Industrials Conference.
-
Declared regular quarterly dividend of $0.08 per share.
-
Elected Michael F. Barry to Board with committee assignments.
-
HRAC granted first dual mode of action classification to rimisoxafen.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
herbicide resistance action committee regulatory
hrac group 13 herbicide technical
pre-emergence technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
"The approval of Isoflex® active addresses a critical gap in agriculture in the European Union," said Sebastià Pons, vice president, president FMC EMEA. "Since the last herbicide approval in 2019, growers have lost access to more than 20 herbicide active ingredients. This approval reinforces our ability to develop and register advanced crop protection solutions that solve grower challenges and help strengthen
Isoflex® active is classified by the Herbicide Resistance Action Committee (HRAC) as a Group 13 herbicide. The molecule provides lasting control of key grass weeds and a wide range of broadleaf weeds, offering growers a new mode of action in cereals, enabling them to effectively manage resistant weed populations and protect economically important crops across the EU.
The European launches will build on FMC's successful global rollout of products powered by Isoflex® active, which have already been registered and commercialized in
For more information about Isoflex® active, visit FMC.com/isoflexactive.
About FMC
FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn®.
FMC and Isoflex are trademarks of FMC Corporation and/or an affiliate. Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions.
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in FMC's other filings with the SEC, and in presentations, reports or letters to FMC stockholders.
In some cases, FMC has identified these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2025 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement.
We specifically decline to undertake any obligation, and specifically disclaims any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-secures-approval-for-isoflex-active-in-the-european-union-addressing-a-critical-gap-in-the-european-herbicide-market-302734929.html
SOURCE FMC Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
